Table 5.

Profile of Patients with Marked Improvements* from Early After Initiation of Brexpiprazole and Remaining on the Drug for ≥1.5 Years

Case Number	Sex	Age (Years)	Type of Schizophrenia	Reason for Treatment	Type of Treatment
1	Male	29	Undifferentiated type	Negative symptoms Blunted affect	Conversion
2	Male	55	Residual type	Negative symptoms Blunted affect	Conversion
3	Female	54	Residual type	Negative symptoms Blunted affect	Conversion
4	Male	52	Schizoaffective disorder	Positive symptoms Hallucinations	Initial treatment for recurrence
5	Female	31	Paranoid type	Positive symptoms Delusion/Impulsivity	Initial treatment for recurrence
6	Female	34	Paranoid type	Positive symptoms Hallucinations	Conversion
7	Male	48	Paranoid type	Positive symptoms Delusion/impulsivity	Conversion
8	Female	48	Paranoid type	Positive symptoms Delusions/impulsivity	Initial treatment for first episode
9	Female	29	Paranoid type	Hallucinations and delusions	Initial treatment for first episode
10	Female	28	Paranoid type	Positive symptoms Delusions/aggression	Initial treatment for first episode

Note: *Marked improvement was defined as scores of 1 on the CGI-I.